Childhood spinal muscular atrophy: controversies and challenges

E Mercuri, E Bertini, ST Iannaccone - The Lancet Neurology, 2012 - thelancet.com
Spinal muscular atrophy is an autosomal recessive disorder characterised by degeneration
of motor neurons in the spinal cord and is caused by mutations of the survival of motor …

New treatments in spinal muscular atrophy: an overview of currently available data

S Ramdas, L Servais - Expert opinion on pharmacotherapy, 2020 - Taylor & Francis
Introduction: Spinal muscular atrophy (SMA) is one of the most common inherited
neuromuscular disorders. It causes progressive muscle weakness and results in significant …

New and developing therapies in spinal muscular atrophy: from genotype to phenotype to treatment and where do we stand?

TH Chen - International journal of molecular sciences, 2020 - mdpi.com
Spinal muscular atrophy (SMA) is a congenital neuromuscular disorder characterized by
motor neuron loss, resulting in progressive weakness. SMA is notable in the health care …

Spinal muscular atrophies

BT Darras, JA Markowitz, UR Monani… - … disorders of infancy …, 2015 - Elsevier
Spinal muscular atrophies (SMAs) are hereditary degenerative disorders of lower motor
neurons associated with progressive muscle weakness and atrophy. Proximal 5q SMA is …

Prospective cohort study of spinal muscular atrophy types 2 and 3

P Kaufmann, MP McDermott, BT Darras, RS Finkel… - Neurology, 2012 - AAN Enterprises
Objective: To characterize the natural history of spinal muscular atrophy type 2 and type 3
(SMA 2/3) beyond 1 year and to report data on clinical and biological outcomes for use in …

209th ENMC international workshop: outcome measures and clinical trial readiness in spinal muscular atrophy 7–9 November 2014, Heemskerk, The Netherlands

R Finkel, E Bertini, F Muntoni, E Mercuri… - Neuromuscular …, 2015 - Elsevier
2. Background Spinal muscular atrophy (SMA) is one of the most common neuromuscular
diseases. While SMA is a monogenic disorder, there is a broad range of phenotypes from …

Treating pediatric neuromuscular disorders: the future is now

JJ Dowling, H D. Gonorazky, RD Cohn… - American Journal of …, 2018 - Wiley Online Library
Pediatric neuromuscular diseases encompass all disorders with onset in childhood and
where the primary area of pathology is in the peripheral nervous system. These conditions …

Spinal muscular atrophy: a clinical and research update

JA Markowitz, P Singh, BT Darras - Pediatric neurology, 2012 - Elsevier
Spinal muscular atrophy, a hereditary degenerative disorder of lower motor neurons
associated with progressive muscle weakness and atrophy, is the most common genetic …

Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study

TO Crawford, SV Paushkin, DT Kobayashi, SJ Forrest… - PloS one, 2012 - journals.plos.org
Background The universal presence of a gene (SMN2) nearly identical to the mutated SMN1
gene responsible for Spinal Muscular Atrophy (SMA) has proved an enticing incentive to …

A qualitative study of perceptions of meaningful change in spinal muscular atrophy

S McGraw, Y Qian, J Henne, J Jarecki, K Hobby… - BMC neurology, 2017 - Springer
Background This qualitative study examined how individuals with Spinal Muscular Atrophy
(SMA), their caregivers, and clinicians defined meaningful change, primarily in the Type II …